结直肠癌
双歧杆菌
癌症
免疫疗法
微生物群
乳腺癌
医学
肿瘤科
疾病
癌症研究
免疫学
内科学
生物
生物信息学
细菌
乳酸菌
遗传学
作者
In Hwan Tae,Jin‐Kwon Lee,Yunsang Kang,Jeong Min Lee,Kunhyang Park,Haneol Yang,Hee-Won Kim,Jeong Heon Ko,Doo-Sang Park,Dae‐Soo Kim,Mi‐Young Son,Hyun‐Soo Cho
出处
期刊:Journal of Microbiology and Biotechnology
[Journal of Microbiology and Biotechnology]
日期:2024-07-12
卷期号:34 (8): 1698-1704
标识
DOI:10.4014/jmb.2404.04055
摘要
Therapeutic advancements in treatments for cancer, a leading cause of mortality worldwide, have lagged behind the increasing incidence of this disease. There is a growing interest in multifaceted approaches for cancer treatment, such as chemotherapy, targeted therapy, and immunotherapy, but due to their low efficacy and severe side effects, there is a need for the development of new cancer therapies. Recently, the human microbiome, which is comprised of various microorganisms, has emerged as an important research field due to its potential impact on cancer treatment. Among these microorganisms,
科研通智能强力驱动
Strongly Powered by AbleSci AI